GTBP

Conviction 0HealthcareScan · Mon, Aug 10, 2026

Three outside up

GTBP$0.3273+2.25%

ResistanceSupportVol 14

Vol MA14 445.02K

May 11May 28Jun 16Jul 6Jul 23Aug 10

GT Biopharma, Inc.Pharmaceutical Preparationswww.gtbiopharma.com ↗

Price0.3273

Change+2.25%

Gap+0.09%

Rel volume0.52×

Avg volume570.47K

Avg $ vol192.98K

SMA 200.3309

SMA 500.4049

SMA 2000.5163

Price vs 50-19.16%

Price vs 200-36.60%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3995

RSI (14)44

MACD hist0.00

MACD crossbull · 1d

Stoch %K / %D59 / 42

ADX (14)35

+DI / −DI11 / 22

RSI divergence—

MACD divergence—

ATR %+9.76%

ADR %9.21%

52w high1.79

52w low0.2720

From 52w high-81.72%

Above 52w low+20.33%

New 52w highNo

SqueezeOff

Bollinger width28.44%

%B0.46

Donchian pos28.10%

Donchian high0.4450

Donchian low0.2813

AVWAP (52w high)0.6771

vs AVWAP high-51.66%

AVWAP (52w low)0.4234

vs AVWAP low-22.69%

OBV trendDown

Chaikin MF (20)-0.19

Today vs 20d0.52×

Avg vol (14d)445.02K

Avg vol (20d)570.47K

Avg $ vol (20d)192.98K

Market cap11.8M

RS 3m (vs SPY)-23.51%

RS 6m (vs SPY)-49.64%

RS line new highNo

Trend template0/8

Technical rank12.6

1 week+6.06%

1 month-22.99%

3 months-12.77%

6 months-39.27%

1 year-82.11%

YTD-59.94%

P/E-0.42

P/B1.56

P/S—

P/FCF-0.91

EPS-6.68

Div yield1.94%

ROE-374.06%

ROA-349.79%

Debt/Eq—

Current4.14

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-115.42%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.88M

Revenue0

Net income-2.83M

Gross profit0

Free cash flow-12.91M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out36.06M

Employees1

ListedThu, Feb 11, 2021

Free float29.5M

Float %93.5%

Short interest4.78M

Days to cover4.2d

Short volume56.8%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.11 vs −$0.08

Last surprise-37.5% miss

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank12.6 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree outside up

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GTBP

All disclosures →

No recent disclosed trades by Congress in GTBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GTBP

No recent insider (Form 4) filings in GTBP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GTBP · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.